Market cap
$14,456 Mln
Revenue (TTM)
$3,357 Mln
P/E Ratio
41.5
P/B Ratio
2.6
Div. Yield
0.2 %
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
14,456 | 26,879 | 13,654 | 11,548 | 11,502 |
Revenue ($ Mln) |
3,357 | 17,664 | 11,470 | 4,140 | 3,145 |
Net Profit ($ Mln) |
396.90 | 1,114.00 | -1,063.00 | 413.58 | 535.46 |
Net Margin (%) |
11.82 | 6.31 | -9.27 | 9.99 | 17.03 |
RoE (%) |
5.44 | 9.93 | -17.24 | 9.99 | 11.46 |
Price to Earnings |
41.45 | 20.99 | -- | 27.60 | 22.54 |
Price-To-Book |
2.57 | 2.04 | 2.22 | 2.67 | 2.49 |
Income Statement ($ Mln)
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
3,357.45 | 17,827.00 | 10,057.00 | 3,734.64 | 1,022.84 |
|
Cost of Revenue
|
1,466.55 | 10,633.00 | 6,508.00 | 1,100.86 | 263.73 |
|
Gross Profit
|
1,989.83 | 7,194.00 | 3,549.00 | 2,633.78 | 759.12 |
|
Operating Expenses
|
1,300.98 | 8,723.00 | 6,394.00 | 1,991.18 | 531.17 |
|
Operating Profit (EBIT)
|
548.52 | -1,529.00 | -2,845.00 | 642.60 | 227.95 |
|
Other Income
|
0.00 | -- | -15.00 | 36.02 | 15.07 |
|
Profit before Tax
|
474.50 | -1,731.00 | -3,248.00 | 599.06 | 243.02 |
|
Provision for Tax
|
93.40 | -113.00 | -135.00 | 237.48 | 52.85 |
|
Profit after Tax (Net Income)
|
396.90 | -1,608.00 | -2,433.00 | 361.57 | 190.17 |
|
Minority Interest
|
0.00 | -- | 62.00 | -- | -- |
|
Consolidated Profit
|
971.69 | -1,608.00 | -2,433.00 | 361.57 | 190.17 |
Liabilities ($ Mln)
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
8,033.81 | 13,249.00 | 5,833.00 | 3,601.36 | 1,846.37 |
|
Minority Interest
|
0.00 | -- | 62.00 | -- | -- |
|
Non-Current Liabilities
|
5,040.61 | 9,471.00 | 17,647.00 | 420.70 | 70.55 |
|
Current Liabilities
|
1,563.74 | 7,934.00 | 4,745.00 | 1,925.89 | 159.20 |
|
Total Liabilities
|
14,126.85 | 30,688.00 | 28,287.00 | 5,947.95 | 2,076.13 |
Assets ($ Mln)
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
10,842.55 | 20,429.00 | 20,276.00 | 3,523.56 | 1,092.78 |
|
Current Assets
|
3,795.61 | 10,259.00 | 8,011.00 | 2,424.39 | 983.34 |
|
Total Assets
|
14,126.85 | 30,688.00 | 28,287.00 | 5,947.95 | 2,076.13 |
|
Total Debt*
|
4,509.80 | 7,342.00 | 17,203.00 | 126.91 | 6.01 |
|
Net Current Assets
|
2,231.87 | 2,325.00 | 3,266.00 | 498.50 | 824.14 |
Cashflow ($ Mln)
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
679.81 | -173.00 | 1,211.00 | 568.73 | 178.47 |
|
Cash Flow from Investing Activities
|
-132.85 | -1,487.00 | -931.00 | -213.32 | -110.36 |
|
Cash from Financing Activities
|
-661.80 | 500.00 | -1,438.00 | -501.69 | -109.96 |
|
Net Cash Inflow / Outflow
|
-122.15 | -- | -1,158.00 | 150.78 | -41.86 |
Ratios
Profitability Ratios
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
4.78 | -7.83 | -9.65 | 9.67 | 10.57 |
|
ROE (%)
|
5.44 | -11.62 | -32.64 | 10.01 | 10.60 |
|
ROA (%)
|
2.46 | -5.22 | -7.87 | 6.08 | 9.43 |
|
EBIT Margin (%)
|
16.34 | -- | -- | -- | -- |
|
Net Margin (%)
|
11.82 | -9.02 | -24.23 | 9.68 | 18.32 |
|
Cash Profit Margin (%)
|
0.00 | -- | -- | -- | -- |
Growth Ratios
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-33.10 | 0.04 | -0.17 | -0.06 | 0.07 |
|
EBIT Growth (%)
|
-51.00 | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-45.62 | -148.45 | -289.49 | -53.17 | 27.47 |
|
EPS Growth (%)
|
-- | -1.49 | -2.89 | -0.52 | 0.30 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -8.55 | -10.62 | 45.31 | 39.92 |
|
Price / Book Value
|
-- | 1.04 | 4.43 | 4.55 | 4.11 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
3.43 | 173.08 | -23.44 | 19.89 | 23.48 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.48 | 0.55 | 2.95 | 0.04 | 0.00 |
|
Short term debt to equity ratio
|
0.06 | 0.02 | 0.26 | 0.01 | 0.00 |
|
Current Ratio
|
2.43 | 1.29 | 1.69 | 1.26 | 6.18 |
|
Quick Ratio
|
2.15 | 0.78 | 1.12 | 1.08 | 4.30 |
|
Interest Coverage
|
5.83 | -6.09 | -6.86 | 121.86 | 16.60 |
Operating Efficiency Ratios
| PerkinElmer (PKI) | Koninklijke Philips N.V. NY Registry Shares - ADR | Baxter International (BAX) | Align Technology (ALGN) | Globus Medical (GMED) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
17.48 | 26.10 | 26.08 | 26.78 | 21.25 |
|
Asset Turnover
|
0.21 | 0.58 | 0.33 | 0.63 | 0.51 |
|
Receivable days
|
90.25 | 91.59 | 96.90 | 97.36 | 68.38 |
|
Inventory Days
|
142.31 | 128.80 | 144.01 | 94.39 | 371.16 |
|
Payable days
|
86.79 | 65.95 | 66.11 | 48.40 | 40.20 |
|
Cash Conversion Cycle
|
145.76 | 154.44 | 174.80 | 143.35 | 399.33 |